Compare Stocks: NDRA, PAVM, ELUT, and IINN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELUT Elutia	$0.85 +4.9%	$0.89	$0.50 ▼ $1.39	$37.65M	0.88	139,505 shs	79,724 shs
IINN Inspira Technologies OXY B.H.N.	$0.83 -2.0%	$1.01	$0.34 ▼ $1.65	$29.79M	2.16	352,435 shs	1.44 million shs
NDRA ENDRA Life Sciences	$5.31 +0.1%	$5.07	$2.96 ▼ $9.85	$7.96M	-0.05	59,657 shs	77,554 shs
PAVM PAVmed	$3.97 +1.3%	$5.05	$3.70 ▼ $28.44	$31.34M	0.53	365,887 shs	8,792 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELUT Elutia	+1.25%	+1.24%	-17.00%	-23.58%	-31.36%
IINN Inspira Technologies OXY B.H.N.	-1.12%	-3.91%	-13.71%	-55.49%	-26.47%
NDRA ENDRA Life Sciences	-5.36%	-9.09%	+18.04%	+11.34%	+10.88%
PAVM PAVmed	0.00%	-13.27%	-26.32%	-24.03%	-67.49%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELUT Elutia	$0.85 +4.9%	$0.89	$0.50 ▼ $1.39	$37.65M	0.88	139,505 shs	79,724 shs
IINN Inspira Technologies OXY B.H.N.	$0.83 -2.0%	$1.01	$0.34 ▼ $1.65	$29.79M	2.16	352,435 shs	1.44 million shs
NDRA ENDRA Life Sciences	$5.31 +0.1%	$5.07	$2.96 ▼ $9.85	$7.96M	-0.05	59,657 shs	77,554 shs
PAVM PAVmed	$3.97 +1.3%	$5.05	$3.70 ▼ $28.44	$31.34M	0.53	365,887 shs	8,792 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELUT Elutia	+1.25%	+1.24%	-17.00%	-23.58%	-31.36%
IINN Inspira Technologies OXY B.H.N.	-1.12%	-3.91%	-13.71%	-55.49%	-26.47%
NDRA ENDRA Life Sciences	-5.36%	-9.09%	+18.04%	+11.34%	+10.88%
PAVM PAVmed	0.00%	-13.27%	-26.32%	-24.03%	-67.49%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELUT Elutia	1.00	Sell	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	1.00	Sell	N/A	N/A
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	371.25% Upside
PAVM PAVmed	2.00	Hold	$56.00	1,310.58% Upside

Current Analyst Ratings Breakdown

Latest NDRA, PAVM, ELUT, and IINN Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/10/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/18/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/14/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (E+)
8/13/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/23/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
7/17/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/7/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
6/17/2026	ELUT Elutia	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)

(Data available from 9/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELUT Elutia	$12.14M	3.10	N/A	N/A	$0.65 per share	1.31
IINN Inspira Technologies OXY B.H.N.	$289K	103.07	N/A	N/A	$0.06 per share	13.81
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1.92 per share	N/A
PAVM PAVmed	$112K	283.43	N/A	N/A	($2.42) per share	-1.64

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELUT Elutia	$53.38M	$0.95	0.89	N/A	N/A	426.93%	-407.37%	-47.08%	11/12/2026 (Estimated)
IINN Inspira Technologies OXY B.H.N.	-$13.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	-$7.03M	-$6.38	N/A	N/A	N/A	N/A	-246.34%	-150.81%	11/13/2026 (Estimated)
PAVM PAVmed	$400K	-$16.05	N/A	N/A	N/A	-10,794.64%	-126.43%	-25.49%	11/12/2026 (Estimated)

Latest NDRA, PAVM, ELUT, and IINN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	-$0.63	+$0.21	$0.06	$0.10 million	N/A
8/13/2026	Q2 2026	ELUT Elutia	-$0.15	-$0.17	-$0.02	-$0.17	$2.90 million	$2.43 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELUT Elutia	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELUT Elutia	N/A	1.77	1.64
IINN Inspira Technologies OXY B.H.N.	0.08	1.56	1.30
NDRA ENDRA Life Sciences	N/A	7.10	7.10
PAVM PAVmed	0.98	1.19	1.19

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELUT Elutia	74.03%
IINN Inspira Technologies OXY B.H.N.	12.72%
NDRA ENDRA Life Sciences	1.19%
PAVM PAVmed	19.93%

Insider Ownership

Company	Insider Ownership
ELUT Elutia	17.80%
IINN Inspira Technologies OXY B.H.N.	29.40%
NDRA ENDRA Life Sciences	10.00%
PAVM PAVmed	13.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELUT Elutia	180	44.29 million	36.41 million	Not Optionable
IINN Inspira Technologies OXY B.H.N.	20	35.95 million	25.38 million	Not Optionable
NDRA ENDRA Life Sciences	20	1.50 million	1.35 million	Not Optionable
PAVM PAVmed	41	8.00 million	6.93 million	No Data

NDRA, PAVM, ELUT, and IINN Headlines

Recent News About These Companies

PAVmed Launches New At-the-Market Equity Offering

September 10, 2026 | tipranks.com

PAVmed (PAVM) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

PAVmed Inc. Q2 2026 Earnings Call Summary

August 14, 2026 | finance.yahoo.com

PAVmed targets early 2027 Veris 510(k) submission while pursuing PortIO 510(k) pathway

August 14, 2026 | seekingalpha.com

PAVmed Inc. (PAVM) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

August 14, 2026 | prnewswire.com

PAVmed (PAVM) Releases Q2 2026 Earnings: Revenue Miss and Continued Losses

August 13, 2026 | quiverquant.comQ

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

August 13, 2026 | prnewswire.com

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test

August 5, 2026 | prnewswire.com

Lucid Diagnostics to Participate in Upcoming Investor Conferences

August 4, 2026 | prnewswire.com

PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026

July 31, 2026 | prnewswire.com

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

July 30, 2026 | prnewswire.com

PAVmed Shareholders Approve Plan Changes at Annual Meeting

June 24, 2026 | tipranks.com

How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target

June 1, 2026 | finance.yahoo.com

PAVmed Inc. (NASDAQ:PAVM) Q1 2026 Earnings Call Transcript

May 16, 2026 | insidermonkey.com

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...

May 15, 2026 | finance.yahoo.com

PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

May 15, 2026 | finanznachrichten.de

PAVmed (PAVM) Q4 2025 Earnings Transcript

May 15, 2026 | finance.yahoo.com

PAVmed targets Varis FDA submission by end of 2026 while evaluating new assets following cap table cleanup

May 15, 2026 | seekingalpha.com

PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript

May 15, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NDRA, PAVM, ELUT, and IINN Company Descriptions

Elutia NASDAQ:ELUT

$0.85 +0.04 (+4.94%)

Closing price 04:00 PM Eastern

Extended Trading

$0.86 +0.01 (+1.65%)

As of 04:10 PM Eastern

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$0.83 -0.02 (-2.01%)

As of 09/16/2026

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

ENDRA Life Sciences NASDAQ:NDRA

$5.30 +0.01 (+0.09%)

Closing price 03:58 PM Eastern

Extended Trading

$5.30 0.00 (-0.09%)

As of 04:10 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

PAVmed NASDAQ:PAVM

$3.97 +0.05 (+1.28%)

Closing price 04:00 PM Eastern

Extended Trading

$4.06 +0.08 (+2.14%)

As of 07:00 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NDRA, PAVM, ELUT, and IINN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NDRA, PAVM, ELUT, and IINN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NDRA, PAVM, ELUT, and IINN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NDRA, PAVM, ELUT, and IINN Company Descriptions

Elutia NASDAQ:ELUT

Inspira Technologies OXY B.H.N. NASDAQ:IINN

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NDRA, PAVM, ELUT, and IINN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NDRA, PAVM, ELUT, and IINN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NDRA, PAVM, ELUT, and IINN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NDRA, PAVM, ELUT, and IINN Company Descriptions

Elutia NASDAQ:ELUT

Inspira Technologies OXY B.H.N. NASDAQ:IINN

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools